Search the NeLM

Medicines A-Z
Find key information about medicines by name (prototype)
NeLM news service
Editorial - Cardiovascular risk in androgen suppression

Reference: Heart 2012; 98:345-348

Source: Heart

Date published: 08/02/2012 16:39

Summary
by: Sheetal Ladva

This editorial discusses the issue of cardiovascular risk in androgen suppression since evidence from observational data suggests that androgen suppression therapy may significantly increase cardiovascular morbidity and mortality.

About this library entry
Category: 6.4.2 Male sex hormones and antagonists | Cancer: prostate
NeLM area:  News
Abstract

Preview your comment

Add new comment

Comment text:

Comments

There are no comments yet. You could be the first! You must be Logged In to comment.
Back